Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Renal Manifestations”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03865914
What this trial is testing

Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Kidney Disease
Chinese PLA General Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT00274118
What this trial is testing

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Who this might be right for
HypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim 250
Not applicableEnded earlyNCT00448526
What this trial is testing

Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Kanazawa Medical University
Post-approval studies (Phase 4)Study completedNCT04238702
What this trial is testing

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Kidney Disease
Amsterdam UMC, location VUmc 24
Testing effectiveness (Phase 2)WithdrawnNCT00398892
What this trial is testing

The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
University of Edinburgh
Not applicableStudy completedNCT05530356
What this trial is testing

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

Who this might be right for
Type 2 DiabetesDiabetes Type 2Diabetic Nephropathies+4 more
University of Colorado, Denver 57
Not applicableUnknownNCT06222476
What this trial is testing

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Who this might be right for
Diabetic Nephropathy Type 2
Yan Bi 106
Testing effectiveness (Phase 2)UnknownNCT04143412
What this trial is testing

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Who this might be right for
Diabetic Nephropathy Type 2Microalbuminuria Due to Type 2 Diabetes Mellitus
Beni-Suef University 75
Large-scale testing (Phase 3)Ended earlyNCT01351675
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 2,185
Not applicableStudy completedNCT00715481
What this trial is testing

Renal Insufficiency And Cardiovascular Events

Who this might be right for
Cardiovascular Disease
Diabetic Nephropathy Study Group 15,628
Not applicableUnknownNCT03413215
What this trial is testing

Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore

Who this might be right for
Diabetes Mellitus, Type 2Diabetic NephropathyHypertension
Changi General Hospital 50
Not applicableUnknownNCT02035891
What this trial is testing

Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Chongqing Medical University 160
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Testing effectiveness (Phase 2)Study completedNCT01667614
What this trial is testing

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Who this might be right for
Type 2 Diabetes MellitusDiabetic NephropathyEssential Hypertension
Tehran University of Medical Sciences 136
Testing effectiveness (Phase 2)Ended earlyNCT04983979
What this trial is testing

The ORTIZ Study: Optimising RASi Therapy With SZC

Who this might be right for
CKDDiabetes Mellitus, Type 2Hyperkalemia
Barts & The London NHS Trust 18
Large-scale testing (Phase 3)Ended earlyNCT00120328
What this trial is testing

To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Speedel Pharma Ltd. 2,364
Not applicableStudy completedNCT00364988
What this trial is testing

Pioglitazone and Losartan Provides Additional Renoprotection

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT05718375
What this trial is testing

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

Who this might be right for
Diabetic Nephropathies
Curacle Co., Ltd. 240
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableNot Yet RecruitingNCT07459946
What this trial is testing

Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence

Who this might be right for
Diabetic Nephropathy Type 2Chronic Renal Failure/ Kidney Disease
Jiazhen Yin 198
Next Page